Medtech
This function is exclusive for Premium subscribers
-
DATABASE (98)
-
ARTICLES (64)
Xiyee Assets was founded in 2016 and is headquartered in Beijing. The firm is involved in private equity investment, M&A, restructuring, real estate and disposal of non-performing assets. It mainly invests in sectors such as advanced manufacturing, new energy, environmental protection, medtech and healthcare.
Xiyee Assets was founded in 2016 and is headquartered in Beijing. The firm is involved in private equity investment, M&A, restructuring, real estate and disposal of non-performing assets. It mainly invests in sectors such as advanced manufacturing, new energy, environmental protection, medtech and healthcare.
Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.
Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Baiyang Capital was founded in 2014 by BAHEAL Pharmaceutical Holdings Limited and several senior professionals in the pharmaceutical and healthcare fields. The investment management company operates multiple funds, targeting pharmaceutical and healthcare businesses.
Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas.
Founded in 2002, Bluesail was initially known as a manufacturer of PVC gloves, with an annual capacity of tens of billions of pairs at its peak. At the end of 2012, it began to expand into more health-related areas.In 2018, it acquired a 93.37% stake in Biosensors International Group that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care. The two companies were merged and Bluesail began to produce more high-end medical consumables. In 2019, the company and senior executives invested in CH Biomedical to collaborate in the development of innovative medical devices for sale in China and overseas.
Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.
Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.
Mubadala was founded in 2017 and was directly listed as a Public Joint Stock Company, merging the Mubadala Development Company and the International Petroleum Investment Company (IPIC).Mubadala is owned by the government of Abu Dhabi in the United Arab Emirates (UAE) with approximately $299bn assets under management and operations across 50 countries. Mubadala owns the Advanced Technology Investment Company (ATIC), a firm acting as an investment vehicle in high technology sectors.
Mubadala was founded in 2017 and was directly listed as a Public Joint Stock Company, merging the Mubadala Development Company and the International Petroleum Investment Company (IPIC).Mubadala is owned by the government of Abu Dhabi in the United Arab Emirates (UAE) with approximately $299bn assets under management and operations across 50 countries. Mubadala owns the Advanced Technology Investment Company (ATIC), a firm acting as an investment vehicle in high technology sectors.
CICFH was co-founded in 2013 by China Investment Securities, ZhongCai Financial Holding Investment and other companies. Based in Tianjin, the VC manages multiple funds worth over RMB 80bn in total.CICFH focuses on M&A in emerging industries and mainly invests in sectors of media, arts, entertainment, healthcare, fintech and environmental technology through multiple funds established with other enterprises. It has also set up multiple FoFs, partnering with provincial governments to spur the development of certain industries.
CICFH was co-founded in 2013 by China Investment Securities, ZhongCai Financial Holding Investment and other companies. Based in Tianjin, the VC manages multiple funds worth over RMB 80bn in total.CICFH focuses on M&A in emerging industries and mainly invests in sectors of media, arts, entertainment, healthcare, fintech and environmental technology through multiple funds established with other enterprises. It has also set up multiple FoFs, partnering with provincial governments to spur the development of certain industries.
Lighthouse Capital is a boutique investment bank established in 2014. The firm has helped to raise finance for over 75 companies, completing more than 120 private funding deals worth over $11bn in total. Its portfolio of companies is valued at over $100bn, including 19 with unicorn status.Lighthouse Capital also manages four PE funds, worth $250bn, targeted at companies in the growth and later stages in emerging sectors.
Lighthouse Capital is a boutique investment bank established in 2014. The firm has helped to raise finance for over 75 companies, completing more than 120 private funding deals worth over $11bn in total. Its portfolio of companies is valued at over $100bn, including 19 with unicorn status.Lighthouse Capital also manages four PE funds, worth $250bn, targeted at companies in the growth and later stages in emerging sectors.
This private Portuguese healthcare group was established in 2000 and based in Lisbon. It made its first investment in a startup in 2019 when it led the €600,000 seed round of medtech UpHill, a SaaS for healthcare professionals to keep up-to-speed on the latest clinical treatments and protocols using AI. The group’s Hospital da Luz was one of UpHill’s first customers.
This private Portuguese healthcare group was established in 2000 and based in Lisbon. It made its first investment in a startup in 2019 when it led the €600,000 seed round of medtech UpHill, a SaaS for healthcare professionals to keep up-to-speed on the latest clinical treatments and protocols using AI. The group’s Hospital da Luz was one of UpHill’s first customers.
Haier Medical, a health-focused IoT-concept brand, is grouped under Yinkang Life, an arm of the Haier Group Corporation. It is an integrated health platform comprising physical hospitals and online medical services. As to its rehabilitation for intensive illnesses, for example, Haier Medical has rehabilitation hospitals that offer both physical treatment and Internet-based consultation so that patients spend less time there than in a normal medical facility. Besides rehabilitation, Haier Medical also focuses on cancer treatment, aged care services, and family health management services. Overall, it has a network of 16 hospitals with 8,000 beds, serving over 1m people every year.
Haier Medical, a health-focused IoT-concept brand, is grouped under Yinkang Life, an arm of the Haier Group Corporation. It is an integrated health platform comprising physical hospitals and online medical services. As to its rehabilitation for intensive illnesses, for example, Haier Medical has rehabilitation hospitals that offer both physical treatment and Internet-based consultation so that patients spend less time there than in a normal medical facility. Besides rehabilitation, Haier Medical also focuses on cancer treatment, aged care services, and family health management services. Overall, it has a network of 16 hospitals with 8,000 beds, serving over 1m people every year.
Zhongguancun Longmen Investment
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Founded at the end of 2019, Youshan Capital has raised RMB 3.3bn for its first fund, landing FOF, listed companies, state-owned companies and government guidance funds as its limited partners. It mainly invests in the sectors including TMT, medtech and advanced manufacturing.
Founded at the end of 2019, Youshan Capital has raised RMB 3.3bn for its first fund, landing FOF, listed companies, state-owned companies and government guidance funds as its limited partners. It mainly invests in the sectors including TMT, medtech and advanced manufacturing.
Greater Bay Area Homeland Development Fund
With the aim of supporting Hong Kong to develop into a world-class tech innovation center and cooperating with Guangdong and Macau enterprises to support the development of the Guangdong-Hong Kong-Macao Greater Bay Area, large-sized mainland enterprises operating in Hong Kong, Hong Kong companies, mainland private firms and new economy enterprises initiated Greater Bay Area Homeland Development Fund in 2018. With a total capital volume of over HK$100bn, it is managed by Greater Bay Area Homeland Investments. The fund will also provide help to enterprises in the Greater Bay Area to export products to overseas markets.
With the aim of supporting Hong Kong to develop into a world-class tech innovation center and cooperating with Guangdong and Macau enterprises to support the development of the Guangdong-Hong Kong-Macao Greater Bay Area, large-sized mainland enterprises operating in Hong Kong, Hong Kong companies, mainland private firms and new economy enterprises initiated Greater Bay Area Homeland Development Fund in 2018. With a total capital volume of over HK$100bn, it is managed by Greater Bay Area Homeland Investments. The fund will also provide help to enterprises in the Greater Bay Area to export products to overseas markets.
Concept Investimentos is a Brazilian mid-market private equity investor based in São Paulo. Focusing mainly on medtech, the firm was established in 2016 with its first investment in Maquira, a leading manufacturer of dental products in Brazil. It has invested in three companies so far, including participation in the R$1.7m seed investment round of Brazilian edtech Blox.Founding partner Rafael Pilotto Gonçalez previously worked at Pacific Investimentos’ private equity division and Pacific’s partnership with One Equity Partners, JPM’s former global private equity arm in Brazil. He has also worked for the private equity arm of Banco Votorantim and London-based private equity firm Actis.
Concept Investimentos is a Brazilian mid-market private equity investor based in São Paulo. Focusing mainly on medtech, the firm was established in 2016 with its first investment in Maquira, a leading manufacturer of dental products in Brazil. It has invested in three companies so far, including participation in the R$1.7m seed investment round of Brazilian edtech Blox.Founding partner Rafael Pilotto Gonçalez previously worked at Pacific Investimentos’ private equity division and Pacific’s partnership with One Equity Partners, JPM’s former global private equity arm in Brazil. He has also worked for the private equity arm of Banco Votorantim and London-based private equity firm Actis.
Bright Success Capital Ltd is a Hong Kong-based family office founded by Hilton Tam who has previously worked at Seagate Technology and Cisco Systems. He specializes in R&D, supply chain processes and consumer electronics manufacturing. Successful investments include Flixibus and N26. The VC manages a portfolio of companies involved in manufacturing and supply chains specifically for hardware components, medical devices, drones and consumer robotics. Its investment focus covers diverse sectors like robotics, fintech, healthcare, enterprise software and deep tech.
Bright Success Capital Ltd is a Hong Kong-based family office founded by Hilton Tam who has previously worked at Seagate Technology and Cisco Systems. He specializes in R&D, supply chain processes and consumer electronics manufacturing. Successful investments include Flixibus and N26. The VC manages a portfolio of companies involved in manufacturing and supply chains specifically for hardware components, medical devices, drones and consumer robotics. Its investment focus covers diverse sectors like robotics, fintech, healthcare, enterprise software and deep tech.
SWITCH Singapore 2021: How to harness the power of the deep tech ecosystem
Investor Jason Illian of Koch Disruptive Technologies talks talent, scaling for deep tech startups, and why longer gestation periods and mid-course pivots don’t have to be deal breakers
SWITCH Singapore 2021: Benefits and challenges of AI applications in healthcare
Medical experts and healthcare startups agree AI can contribute more to healthcare beyond improving diagnosis and personalized treatment, but hurdles still remain
Sequoia China Seed Fund: Growing an era of deep-tech startups
Managing Partner Neil Shen wants to help deep-tech and enterprise tech startups get investments more easily, across quantum computing, semiconductors, synthetic biology and more
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Intudo Ventures: Grooming returning overseas talent for an Indonesia-only bet
Combining the experience and networks of foreign-educated Indonesians with local distribution channels, Intudo’s hyperlocal strategy has attracted $200m in managed assets
ARTICARES: Personalized, more affordable arm rehab therapy at home
Using adaptive AI, its H-Man robot works like an occupational therapist, assessing patient’s performance and adjusting the complexity of training tasks in real time
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
New sectors, strategies come into play as investors respond to China's Big Tech curbs
Amid the crackdown on China’s tech giants, some investors are sussing out less risky sectors, while heavyweights like BlackRock and Fidelity stay in for the long haul
Aimentia: Pioneering mental health AI SaaS seeks to improve diagnosis as demand surges
Barcelona-based Aimentia supports the oft-overlooked mental health segment through digitalization and analytics, going beyond therapy platforms
Zoundream: Deciphering and mining the data in baby cries
The world’s first algorithm to translate baby cries into actionable insights for parents and hospitals seeks to boost early detection of pathologies and developmental disorders
Nuuk, the cooler box poised to disrupt cold chain logistics
Barcelona-based startup Groenlandia Tech has developed a smart cooler box to track and monitor biological samples, providing an extra layer of security and control during transport
Vence: Virtual fencing for sustainable livestock rearing
The startup uses GPS and AI algorithms to create virtual fences that work with animal collars for more efficient management of livestock and grasslands
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
Therapixel: Using AI to improve breast cancer detection
Therapixel is raising €15m for commercial expansion of its AI-powered MammoScreen that gives accurate breast cancer screening results within minutes
HumanITcare: Covid-19 spurs demand for telemedicine across Spain and beyond
The startup’s revenue is expected to exceed €10m by 2024 due to rapid digital transformation of healthcare services and a growing market for AI-powered medtechs
POPULAR DATABASE
